Stocktoria
Grifols, S.A. GRF.MC
Grifols, S.A. (GRF.MC) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the grey zone. It pays a dividend yielding 2.10% (safety: safe). FY2025 revenue was $7.5B at a 5.3% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Healthcare · percentile among 23 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · grey zone
| Component | Value |
|---|---|
| Working capital / assets | 0.155 |
| Retained earnings / assets | 0.015 |
| EBIT / assets | 0.063 |
| Equity / liabilities | 0.435 |
FAQ
Is GRF.MC financially healthy?
Grifols, S.A.'s Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the grey zone.
Does GRF.MC pay a dividend, and is it safe?
Yes. Grifols, S.A. pays a dividend yielding about 2.10% with a 31.8% payout ratio, rated “safe” for safety.
How profitable is GRF.MC?
In FY2025, Grifols, S.A. had a net margin of 5.3% and a return on equity of 7.6%.
Source: company filings via Yahoo Finance · ES · as of 2025-12-31. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.